Cited 6 times in

The Current Status of BCG Vaccination in Young Children in South Korea

DC Field Value Language
dc.contributor.author이혜존-
dc.date.accessioned2019-01-15T16:40:04Z-
dc.date.available2019-01-15T16:40:04Z-
dc.date.issued2012-
dc.identifier.issn1738-3536-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/166601-
dc.description.abstractBackground: Delivery of Bacille Calmette-Guréin (BCG) Tokyo vaccine, with the multipuncture device, has been much preferred over BCG Pasteur, with the intradermal method, possibly due to the easier manner of administration, a desire to avoid any trouble with scars, as well as side effects and higher profits to providers in South Korea. Methods: To determine BCG scar status in 0∼6 year old children vaccinated with two BCG vaccines (Pasteur BCG vaccine with intradermal method and BCG Tokyo vaccine with percutaneous method), the data from the national BCG scar survey in 2006 was analyzed. Results: Based on the national survey, the high proportion that were vaccinated with BCG Tokyo vaccines with the multipuncture method (64.5%) was noted in 0∼6 year old Korean children. From inspection of scar formation, as an indicator of vaccination, the median number of the visible pin scars from the percutaneous method was 16 (interquartile range, 12∼18) in the Korean children, and pin scars decreased as the age of the children increased (p<0.001). Conclusion: The findings in this survey clearly showed a growing preference of parents for the BCG Tokyo vaccines by the multipuncture method in South Korea.-
dc.description.statementOfResponsibilityopen-
dc.formatapplication/pdf-
dc.languageKorean-
dc.publisher대한결핵 및 호흡기학회-
dc.relation.isPartOfTUBERCULOSIS AND RESPIRATORY DISEASES-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.rightshttps://creativecommons.org/licenses/by-nc-nd/2.0/kr/-
dc.titleThe Current Status of BCG Vaccination in Young Children in South Korea-
dc.typeArticle-
dc.contributor.collegeResearch Institutes (연구소)-
dc.contributor.departmentInstitute for Immunology and Immunological Disease (면역질환연구소)-
dc.contributor.googleauthorHyejon Lee-
dc.contributor.googleauthorHazel M. Dockrell-
dc.contributor.googleauthorDeok Ryun Kim-
dc.contributor.googleauthorSian Floyd-
dc.contributor.googleauthorSue Yeon Oh-
dc.contributor.googleauthorJin Bum Lee-
dc.contributor.googleauthorHee Jin Kim-
dc.identifier.doi10.4046/trd.2012.72.4.374-
dc.contributor.localIdA04865-
dc.relation.journalcodeJ02761-
dc.identifier.eissn2005-6184-
dc.identifier.pmid23227079-
dc.subject.keywordBCG Vaccine-
dc.subject.keywordTuberculosis-
dc.subject.keywordVaccination-
dc.contributor.alternativeNameLee, Hyejon-
dc.contributor.affiliatedAuthor이혜존-
dc.citation.volume72-
dc.citation.startPage374-
dc.citation.endPage380-
dc.identifier.bibliographicCitationTUBERCULOSIS AND RESPIRATORY DISEASES, Vol.72 : 374-380, 2012-
dc.identifier.rimsid57878-
dc.type.rimsART-
Appears in Collections:
1. College of Medicine (의과대학) > Research Institute (부설연구소) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.